SEC Form 4 Reporting Owner · CIK 0001643653
Eric Benevich
Officer at Neurocrine Biosciences Inc · Director at aTYR Pharma Inc
Bought (12 mo)
—
Sold (12 mo)
−$1.24M
Form 4 Filings
31
Companies
2
Filing Activity
2026-09-15
first filed 2021-01-27
Trading record
Open-market buys
—
0 filings
Open-market sales
−$41.3M
23 filings
Sales under a 10b5-1 plan
100%
23 of 23 sale filings
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| NBIXNeurocrine Biosciences Insider trading | Officer | 28 | — | 320,009 | −320,009 | 70,683 2026-09-15 |
| ATYRaTYR Pharma Insider trading | Director | 3 | — | — | — | — |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.